Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BioLargo, Inc. (BLGO) had Revenue of $1.10M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$1.10M
Net Income	$-6.48M
Cost of Goods Sold	$0.73M
Gross Profit	$0.37M
Operating Expenses	$8.28M
Operating Income	$-7.18M
Non-Operating Income/Expense	$-0.06M
Pre-Tax Income	$-7.24M
Normalized Pre-Tax Income	$-7.24M
Income after Taxes	$-7.24M
Income from Continuous Operations	$-7.24M
Consolidated Net Income/Loss	$-7.24M
Normalized Income after Taxes	$-7.24M
EBIT	$-7.18M
EBITDA	$-7.04M
Weighted-Average Shares Outstanding (Basic)	308.97M
Weighted-Average Shares Outstanding (Diluted)	308.97M
Earnings per Share (EPS) (Basic)	$-0.02
Earnings per Share (EPS) (Diluted)	$-0.02
Balance Sheet Financials
Current Assets	$5.78M
Property, Plant, and Equipment	$1.66M
Long-Term Assets	$3.35M
Total Assets	$9.13M
Current Liabilities	$3.45M
Long-Term Debt	$1.50M
Long-Term Liabilities	$2.46M
Total Liabilities	$5.92M
Common Equity	$3.21M
Tangible Shareholders Equity	$3.21M
Shareholders Equity	$3.21M
Common Shares Outstanding	311.45M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-6.71M
Cash Flow from Investing Activities	$0.45M
Cash Flow from Financial Activities	$7.27M
Beginning Cash	$3.55M
End Cash	$4.55M
Increase/Decrease in Cash	$1.00M
Stock-Based Compensation	$2.34M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.67
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.32
Debt to Equity Ratio	0.84
Gross Margin	33.73%
Operating Margin	-650.95%
EBIT Margin	-650.95%
EBITDA Margin	--
Pre-Tax Profit Margin	-656.75%
Profit Margin	-587.40%
Free Cash Flow	$-6.74M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	1.79
Receiveable Turnover	1.45
Days Sales in Receivables	62.09
Return on Equity	-225.32%
Return on Tangible Equity	-225.32%
Return on Assets	-79.34%
Return on Investments	-153.80%
Book Value Per Share	$0.01
Free Cash Flow per Share	$-0.02
Operating Cash Flow per Share	$-0.02

Data from Zacks Investment Research, Inc.